ArticleFrontiers in psychiatry2026
The relationship between the latent profiles of alexithymia and self-disclosure in female patients with pelvic floor dysfunction.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alexithymia is common among female patients with pelvic floor dysfunction (PFD) and has been associated with negative emotions, poorer quality of life, impaired disease management, and reduced self-disclosure. This study aimed to identify latent profiles of alexithymia among female patients with PFD, examine factors associated with profile membership, and investigate the association between these profiles and self-disclosure. Methods: A cross-sectional study was conducted with 450 female patients with PFD in Urumqi, Xinjiang, China, from December 2025 to April 2026. Data were collected using a general information questionnaire, the Toronto Alexithymia Scale (TAS-20), and the Distress Disclosure Index (DDI). Latent profile analysis was employed to identify distinct alexithymia profiles. Multivariate logistic regression was used to analyze sociodemographic variables within each profile, and ANOVA was used to examine relationships between alexithymia profiles and self-disclosure. Results: Alexithymia in female patients with PFD can be categorized into three profiles: low-level alexithymia group( Conclusion: Alexithymia in female patients with PFD can be categorized into three profiles, with significant differences in self-disclosure levels across these subgroups. Assessing alexithymia may help identify high-risk patients with insufficient self-disclosure and provide a basis for stratified, individualized support for emotional expression and communication. Future longitudinal studies are needed to clarify further the temporal and causal relationships between alexithymia and self-disclosure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.